|
ATNF
|
180 Life Sciences Corp.
|
US
|
NASDAQ
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
GRTX
|
Galera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IVA
|
Inventiva S.A.
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SRRK
|
Scholar Rock Holding Corporation
|
US
|
NASDAQ
|
|
1AD
|
Adalta Ltd
|
AU
|
ASX
|
|
ATX
|
Amplia Therapeutics Limited
|
AU
|
ASX
|
|
PXS
|
Pharmaxis Ltd.
|
AU
|
ASX
|
|
VBS
|
Vectus Biosystems Ltd
|
AU
|
ASX
|
|
ACHFF
|
Arch Biopartners Inc
|
US
|
OTC
|
|
AOLS
|
Aeolus Pharmaceuticl
|
US
|
OTC
|
|
GLPGF
|
Galapagos Genomics Ord
|
US
|
OTC
|
|
INNMF
|
Amplia Therapeutics Limited
|
US
|
OTC
|
|
OXBDF
|
Oxford Biomedical Lt
|
US
|
OTC
|
|
SSMXF
|
Sysmex Corporation
|
US
|
OTC
|
|
SSMXY
|
Sysmex Corp ADR
|
US
|
OTC
|
|
VRCDF
|
Verici Dx Plc
|
US
|
OTC
|